Pentwater Capital Management LP - ACCELERON PHARMA INC ownership

ACCELERON PHARMA INC's ticker is XLRN and the CUSIP is 00434H108. A total of 339 filers reported holding ACCELERON PHARMA INC in Q3 2021. The put-call ratio across all filers is 0.38 and the average weighting 0.5%.

Quarter-by-quarter ownership
Pentwater Capital Management LP ownership history of ACCELERON PHARMA INC
ValueSharesWeighting
Q3 2021$180,705,000
+7398.1%
1,050,000
+985.0%
1.84%
+8642.9%
Q3 2015$2,410,000
-64.1%
96,771
-54.4%
0.02%
-41.7%
Q2 2015$6,708,000
+114.9%
212,000
+158.5%
0.04%
+56.5%
Q1 2015$3,121,000
+0.1%
82,000
+2.5%
0.02%
+4.5%
Q4 2014$3,117,00080,0000.02%
Other shareholders
ACCELERON PHARMA INC shareholders Q3 2021
NameSharesValueWeighting ↓
Novo Holdings A/S 1,103,937$53,563,0005.39%
GREAT POINT PARTNERS LLC 758,000$36,778,0005.10%
Foresite Capital Management II, LLC 244,756$11,876,0004.18%
GREAT POINT PARTNERS LLC 552,300$26,798,0003.71%
Foresite Capital Management III, LLC 278,753$13,525,0002.91%
QVT Financial LP 190,977$9,266,0002.66%
Perceptive Advisors 1,528,205$74,149,0001.94%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 1,126,800$54,672,0001.92%
SECTORAL ASSET MANAGEMENT INC 306,626$14,877,0001.66%
Parametrica Management Ltd 5,645$274,0001.30%
View complete list of ACCELERON PHARMA INC shareholders